Cell therapy and gene therapy aims to treat, prevent, or potentially cure diseases. It has the potential to alleviate the underlying cause of genetic diseases and acquired diseases. 预计复合年增长率为 28.2% 从 2022 到 2028, the global cell and gene therapy market will worth USD 21,508 到 2028 年底将达到 100 万, 据Gen Consulting公司称.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global cell and gene therapy market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the cell and gene therapy industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, therapy type, therapeutic class, 和地区. The global market for cell and gene therapy can be segmented by product: epicel, gendicine, imlygic, kymriah, luxturna, maci, provenge, strimvelis, tecartus, yescarta, zolgesma, zynteglo, 其他的. The zolgesma segment captured the largest share of the market in 2021. Cell and gene therapy market is further segmented by therapy type: cell therapy, gene modified cell therapy, gene therapy. Based on therapeutic class, the cell and gene therapy market is segmented into: hematology, 神经病学, 肿瘤学, ophthalmology, rare diseases, 其他的. 根据地区, the cell and gene therapy market also can be divided into: 亚太地区, 欧洲, 北美, 世界其他地区 (排).

副产品:
– epicel
– gendicine
– imlygic
– kymriah
– luxturna
– maci
– provenge
– strimvelis
– tecartus
– yescarta
– zolgesma
– zynteglo
– 其他的

By therapy type:
– cell therapy
– gene modified cell therapy
– gene therapy

By therapeutic class:
– hematology
– 神经病学
– 肿瘤学
– ophthalmology
– rare diseases
– 其他的

按地区:
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The global cell and gene therapy market report offers detailed information on several market vendors, including Amgen Inc., bluebird bio, 公司, 百时美施贵宝公司 (电池管理系统), Dendreon Pharmaceuticals, 公司, Gilead Sciences, 公司, Human Stem Cells Institute PJSC (HSCI), 诺华国际公司, Orchard Therapeutics plc, Organogenesis Holdings Inc., Shanghai Sunway Biotech Co., 有限公司, Shenzhen Sibiono GeneTech Co., 有限公司. (Sibiono), Spark Therapeutics, 公司, Vericel Corporation, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global cell and gene therapy market.
– To classify and forecast the global cell and gene therapy market based on product, therapy type, therapeutic class, 地区.
– To identify drivers and challenges for the global cell and gene therapy market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global cell and gene therapy market.
– To identify and analyze the profile of leading players operating in the global cell and gene therapy market.

为什么选择这份报告
– Gain a reliable outlook of the global cell and gene therapy market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.